Literature DB >> 18436827

Repertoire analysis and new pathogenic epitopes of IRBP in C57BL/6 (H-2b) and B10.RIII (H-2r) mice.

Lizette M Cortes1, Mary J Mattapallil, Phyllis B Silver, Larry A Donoso, Gregory I Liou, Wei Zhu, Chi-Chao Chan, Rachel R Caspi.   

Abstract

PURPOSE: Interphotoreceptor retinoid binding protein (IRBP) is the major uveitogenic retinal antigen eliciting experimental autoimmune uveoretinitis (EAU) in mice. The most frequently used mouse strains are B10.RIII and C57BL/6, but to date only one uveitogenic epitope for each has been identified. The purpose of this study was to identify and characterize additional uveitogenic epitopes in B10.RIII and C57BL/6 mice and to compare epitope recognition in wild-type versus IRBP-deficient mice on both backgrounds.
METHODS: Mice were immunized with IRBP. Spleen cells were stimulated in culture with overlapping peptides representing the entire IRBP molecule, and lymphocyte proliferative responses were measured. Peptides determined to be immunodominant were used to immunize mice for EAU. Cytokine profile and proliferation of the CD4 versus CD8 subsets were analyzed for the most pathogenic peptides.
RESULTS: Two new major pathogenic epitopes were identified in WT C57BL/6 mice, residues 461-480 and 651-670. These epitopes induced EAU of severity similar to that induced by the previously known peptide, 1-20. Several other peptides elicited mild disease with lower incidence. Some peptides elicited EAU only in WT recipients of IRBP KO splenocytes. In the B10.RIII strain, two major new uveitogenic peptides were identified, 171-190 and 541-560, and several others elicited moderate disease. Unlike in C57BL/6 mice, adoptive transfer of WT B10.RIII with IRBP KO splenocytes did not reveal additional uveitogenic epitopes. Both CD4 and CD8 lymphocyte subsets proliferated to pathogenic peptides.
CONCLUSIONS: Several new pathogenic peptides of IRBP were identified in C57BL/6 and B10.RIII mice. Differences in epitope recognition between WT and IRBP KO mice were observed in C57BL/6 mice, but not in B10.RIII mice, suggesting more extensive culling of the repertoire in C57BL/6 mice by endogenously expressed IRBP.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18436827      PMCID: PMC2442582          DOI: 10.1167/iovs.07-0868

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  25 in total

Review 1.  Proctor Lecture. Experimental autoimmune uveitis: mechanisms of disease and clinical therapeutic indications.

Authors:  R B Nussenblatt
Journal:  Invest Ophthalmol Vis Sci       Date:  1991-12       Impact factor: 4.799

2.  Human interstitial retinoid binding protein. A potent uveitopathogenic agent for the induction of experimental autoimmune uveitis.

Authors:  L A Donoso; C F Merryman; T Sery; R Sanders; T Vrabec; S L Fong
Journal:  J Immunol       Date:  1989-07-01       Impact factor: 5.422

3.  Experimental autoimmunity.

Authors:  R B Nussenblatt; H C Gunn; B Ryffel; J F Borel
Journal:  Prog Allergy       Date:  1986

4.  Pathology of experimental autoimmune uveoretinitis in mice.

Authors:  C C Chan; R R Caspi; M Ni; W C Leake; B Wiggert; G J Chader; R B Nussenblatt
Journal:  J Autoimmun       Date:  1990-06       Impact factor: 7.094

5.  A new model of autoimmune disease. Experimental autoimmune uveoretinitis induced in mice with two different retinal antigens.

Authors:  R R Caspi; F G Roberge; C C Chan; B Wiggert; G J Chader; L A Rozenszajn; Z Lando; R B Nussenblatt
Journal:  J Immunol       Date:  1988-03-01       Impact factor: 5.422

6.  Immune responses to peptides derived from the retinal protein IRBP: immunopathogenic determinants are not necessarily immunodominant.

Authors:  T M Redmond; H Sanui; L H Hu; B Wiggert; H Margalit; J A Berzofsky; G J Chader; I Gery
Journal:  Clin Immunol Immunopathol       Date:  1989-11

Review 7.  Humoral and cellular immune reactions against retinal antigens in clinical disease.

Authors:  A Kijlstra; R Hoekzema; A vd Lelij; G Doekes; A Rothova
Journal:  Curr Eye Res       Date:  1990       Impact factor: 2.424

8.  In vitro unresponsiveness to autologous sequences of the immunopathogenic autoantigen, S-antigen.

Authors:  S P Fling; L A Donoso; D S Gregerson
Journal:  J Immunol       Date:  1991-07-15       Impact factor: 5.422

9.  Functional properties of interphotoreceptor retinoid-binding protein.

Authors:  D R Pepperberg; T L Okajima; H Ripps; G J Chader; B Wiggert
Journal:  Photochem Photobiol       Date:  1991-12       Impact factor: 3.421

10.  Early expression of the gene for interphotoreceptor retinol-binding protein during photoreceptor differentiation suggests a critical role for the interphotoreceptor matrix in retinal development.

Authors:  F Gonzalez-Fernandez; J I Healy
Journal:  J Cell Biol       Date:  1990-12       Impact factor: 10.539

View more
  23 in total

1.  Understanding autoimmune uveitis through animal models. The Friedenwald Lecture.

Authors:  Rachel R Caspi
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-03-30       Impact factor: 4.799

2.  An Ocular Commensal Protects against Corneal Infection by Driving an Interleukin-17 Response from Mucosal γδ T Cells.

Authors:  Anthony J St Leger; Jigar V Desai; Rebecca A Drummond; Abirami Kugadas; Fatimah Almaghrabi; Phyllis Silver; Kumarkrishna Raychaudhuri; Mihaela Gadjeva; Yoichiro Iwakura; Michail S Lionakis; Rachel R Caspi
Journal:  Immunity       Date:  2017-07-11       Impact factor: 31.745

3.  Complement anaphylatoxin receptors C3aR and C5aR are required in the pathogenesis of experimental autoimmune uveitis.

Authors:  Lingjun Zhang; Brent A Bell; Minzhong Yu; Chi-Chao Chan; Neal S Peachey; John Fung; Xiaoming Zhang; Rachel R Caspi; Feng Lin
Journal:  J Leukoc Biol       Date:  2015-09-22       Impact factor: 4.962

4.  AS101 ameliorates experimental autoimmune uveitis by regulating Th1 and Th17 responses and inducing Treg cells.

Authors:  So Jin Bing; Itay Shemesh; Wai Po Chong; Reiko Horai; Yingyos Jittayasothorn; Phyllis B Silver; Benjamin Sredni; Rachel R Caspi
Journal:  J Autoimmun       Date:  2019-03-08       Impact factor: 7.094

5.  Characterization of a New Epitope of IRBP That Induces Moderate to Severe Uveoretinitis in Mice With H-2b Haplotype.

Authors:  Mary J Mattapallil; Phyllis B Silver; Lizette M Cortes; Anthony J St Leger; Yingyos Jittayasothorn; Jennifer L Kielczewski; James J Moon; Chi-Chao Chan; Rachel R Caspi
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-08       Impact factor: 4.799

6.  A novel pathogenic RBP-3 peptide reveals epitope spreading in persistent experimental autoimmune uveoretinitis.

Authors:  Joanne Boldison; Tarnjit K Khera; David A Copland; Madeleine L Stimpson; Gemma L Crawford; Andrew D Dick; Lindsay B Nicholson
Journal:  Immunology       Date:  2015-08-11       Impact factor: 7.397

Review 7.  Autoimmunity in the immune privileged eye: pathogenic and regulatory T cells.

Authors:  Rachel Caspi
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

8.  Fertility comparison between wild type and transgenic mice by in vitro fertilization.

Authors:  Kuzhalini Vasudevan; James Raber; Jorge Sztein
Journal:  Transgenic Res       Date:  2009-10-21       Impact factor: 2.788

Review 9.  Mouse models of experimental autoimmune uveitis.

Authors:  Rachel R Caspi; Phyllis B Silver; Dror Luger; Jun Tang; Lizette M Cortes; Giuseppina Pennesi; Mary J Mattapallil; Chi-Chao Chan
Journal:  Ophthalmic Res       Date:  2008-04-18       Impact factor: 2.892

10.  Inhibitory peptide analogs derived from a major uveitogenic epitope protect from antiretinal autoimmunity by inducing type 2 and regulatory T cells.

Authors:  Lizette M Cortes; Dody Avichezer; Phyllis B Silver; Dror Luger; Mary J Mattapallil; Chi-Chao Chan; Rachel R Caspi
Journal:  J Leukoc Biol       Date:  2008-05-21       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.